赵澄泉

赵澄泉，医学博士，UPMC-中国企业病理部主任。美国匹兹堡大学医学院教授，妇病理学/乳房病理学和细胞病理学专家,细胞病理学共同主任。
青岛医学院77级医学系学生，1983年毕业后留校在青岛医学院附属医院检验科工作曾任检验科副主任。

学习及工作经历：

1985-1988年在青岛医学院微生物硕士学习，随留校在微生物学和免疫学教研室任教。

1992年赴以色列希伯来大学从事DNA重组的分子生物学研究。

1993.10-2000.06在美国加州大学洛杉矶分校医学院(UCLA)从事抗菌肽分子生物学研究。科研成果获三项美国国家专利局专利。

2000.07开始在美国Drexel大学医学院接受四年病理学训练。后在美国国防部部队病理学研究院（AFIP）完成一年的妇产科病理学和乳房病理学专科训练，和在南加州大学(USC)专攻一年细胞病理学。

2006年至今，在匹兹堡大学医学中心Magee妇产科医院从事乳房病理学/妇产科外科病理学和细胞病理学的临床诊断，教学和科研工作，任细胞病理学共同主任，细针穿刺主任。因为工作和科研成绩突出，经过6年，由助理教授，副教授，破格晋升为匹兹堡大学医学院正教授。

科研方向：

妇科肿瘤的病理诊断和分子生物学及妇科宫颈细胞学，HPV的研究。

科研论文：

现有2个NIH-R01研究课题做为共同研究者。已发表医学论文170余篇，论文摘要120篇。会议宣读科研和受邀讲课100余次。 

社会职务：
现为多个病理学学会会员，美国病理学院(CAP) 细胞病理学委员会委员，ASCCP学会国际教育及拓展委员会委员，美国细胞病理学学会几个委员会委员。参入2013 WHO妇科肿瘤分类的编写。任大约20家英文医学杂志编委或特约审稿人。
积极参入中国国内病理医生教育活动，兼任上海复旦大学妇产医院，中国人民解放军301总院，中南大学湘雅医院，山西医科大学第二临床医学院，新乡医学院等多所中国国内大学和医院特聘/客座教授。中国优生科学协会阴道镜和宫颈病理学分会(CSCCP) 首席海外医学顾问，中华妇产科学会病理组/中国医疗保健国际交流促进会海外顾问, 中国病理学杂志编委会海外编委。

编译著作：

主编和叁入国内多部医学书籍的编写和翻译。主编妇科细胞病理学诊断与临床处理；细针穿刺细胞病理学；非妇科脱落细胞病理学, 乳腺病理诊断和鉴别诊断；实用妇科细胞学教程。翻译英文专著任主审Blaustein女性生殖道病理学(第6版）；乳腺病理活检解读；乳腺病理诊断难点；乳腺病理活检解读(第2版)，子宫颈和子宫体活检解读（第2版），现代阴道镜学。积极参入中国病理网络教学和培训，负责策划和编排网络学院《宫颈细胞病理学》，《细针穿刺细胞学》,《脱落细胞学》课程。

CURRICULUM VITAE

    Chengquan Zhao, M.D.

APPOINTMENTS AND POSITIONS

    Professor of Pathology, University of Pittsburgh Medical School

    Gynecologic/Breast Surgical Pathologist and Cytopathologist

    Co-Director of Cytopathology, Director of Fine Needle Aspiration, Magee-Womens Hospital

    Chief of Pathology, UPMC-China Enterprises.

Working hospitals:

    Magee-Womens Hospital-UPMC; Shadyside Cancer Center-UPMC.

    China: Actively involve pathology education in China

Guest/visiting professor:

    General Hospital of People’s Liberation Army (301 hospital)/medical school, China

    Women Hospital of Fuda University, China

    Anhui Province Women and Children Hospital, Hefei, Anhui, China

    BinZhou Medical College, Yantai, Shandong, China

    Qingdao University, Shandong, China

    Editorial board of Chinese Journal of Pathology

    2016-current Magee-Women Hospital, UPMC，Co-Director of Cytopathology

    2016-currentDepartment of Pathology, UPMC，Chief of Pathology, China-Enterprise

    2012-9 -currentUniversity of Pittsburgh, School of Medicine， Professor of Pathology

EDUCATION

    Jan 2013-June, 2013  UPMC and Katz Graduate School of Business, University of Pittsburgh Certificate of 2013 Marshall W. Webster Physician Leadership Program

TRAINING

CERTIFICATION AND LICENSURE

SPECIALTY CERTIFICATION:

    Certifying Board Year:

    American Board of Pathology, Cytopathology  September, 2006

    American Board of Pathology, (combined AP/CP)   August, 2005

    ECFMG January, 1998

MEDICAL OR OTHER PROFESSIONAL LICENSURE:

    Licensing Board/State Year

    Medical Board of California March, 2003

    Board of Medicine, District of Columbia May, 2004

    Bureau of Professional and Occupational Affairs, PA    May, 2004

SERVICE IN EDITORIAL BOARD AND JOURNAL REVIEWER

    American Journal of clinical and experimental obstetrics and gynecology (senior editorial board)

    American Journal of Clinical Pathology (editorial board)

    Diagnostic Pathology (editorial board)

    World Journal of Obstetrics and Gynecology (editorial board)

    Journal of Cancer (editorial board)

    International Scholarly Research Network Pathology (editorial board)

    Open Journal of Obstetrics and Gynecology (editorial board)

    Journal of Chinese Clinical Medicine (editorial board)

    Dataset Paper in Medicine (editorial board)

    Am J Clin Exp Obstetrics and Gynecology (editorial board)

    Chinese Journal of Pathology (editorial board)

    Huaxia Pathology Information Net, Chief Academic editor

    American Journal of Obstetrics and Gynecology

    Journal of Obstetrics and Gynecology Research

    Journal of Ovarian Research

    Cancer Cytopathology

    Diagnostic Cytopathology

    European Journal of Obstetrics & Gynecology and Reproductive Biology

    International Journal of Biological Science

    Applied Immunohistochemistry & Molecular Morphology

    Gynecology Oncology

    Human Pathology

    Cytojournal

    Cytopathology

    Histology and Histopathology

    Cancer Management and Research

    International Journal of Women’s Health

    Cambridge University Press (book proposal review)

HONORS

    Title of Award; Year

    Golda Meir Foundation Postdoctoral Fellow, Hebrew University      1992-1993

    Outstanding Scientific Research Award, Qingdao Medical College1991

    Young Scientific leader Trained by the Education Committee of Shandong Provinces 1990

    United States Patent, Clavanins, #6040293 March 21, 2000

    United States Patent, Clavanins, #6010876 January 4, 2000

    United States Patent, Clavaspirins, #5998374December 7, 1999

    Pap Cytology and Hybrid Capture 2 HPV DNA Testing in 234 Patients with Cervical Squamous Carcinoma Li Z, Gao M, Austin RM, Zhao C. 2011 best abstract award by Chinese American Pathologist Association

    The award of Huaxia Education, Huaxia Pathology. March 2011.

    Li Z, Gilbert C, Yang H, Zhao C. Histologic follow-up results in patients with Pap test findings of endometrial cells: Results from a large academic women hospital laboratory. 2012 best abstract award by Chinese American Pathologist Association

    UPMC Department of Pathology Resident Research mentor award nomination, 2012

RESEARCH GRANTS INVOLVED

    Title:  Alteration of 3D nuclear organization at nanoscale in breast tumorigenesis.

    Principle Investigator: Yang Liu, PhD, University of Pittsburgh

    Agency: National Cancer Institute

    Agency Number: R01CA185363

    Amount of funding: $1,272,488 total ($830,000 direct cost and $442,488 indirect cost).

    Co-investigator

    Percentage effort 4%

    Years: 05/01/2014-04/30/2018

    Title:  Novel nanoscale single-cell analysis of exfoliative cytology

    Principle Investigator: Yang Liu, PhD, University of Pittsburgh

    Agency: National Institute of Biomedical Imaging and Bioengineering

    Agency Number: R01 EB016657

    Amount of Funding: $1,332,074 total ($900,000 direct cost and $432,074 indirect cost).

    Co-investigator

    Percentage effort 9% for year 1-2; 13.5% for year 3-4

    Years: 04/01/2013-03/30/2017

    Title:  Nano-architecture based biomarkers for cervical cancer screening.

    Principle Investigator: Yang Liu, PhD, University of Pittsburgh

    Agency: National Cancer Institute

    Amount of Funding: $359,478 total ($239,250 direct cost and $120,228 indirect cost).

    Co-investigator

    Percentage effort 10%

    Years: 05/01/2012-04/30/2014

    Title: The study on abnormal methylation on related cancer inhibitor genes in cervical cancer tissue

    Principle Investigator: Yankui Wang, MD, Qingdao Medical University, School of Medicine

    Agency: Chinese National Nature Science Grants

    Starting in 2011. 600,000 RMB

    The first co-investigator

    2007 University of Pittsburgh Department of Pathology research grants: Cervical cancer screening and HPV infection.US$ 30,000

    2008 University of Pittsburgh Department of Pathology research grants: Cervical cancer screening and HPV infection.US$ 30,000

    2009 University of Pittsburgh Department of Pathology research grants: Cervical cancer screening and HPV infection.US$ 30,000

    Title of Project: Defensins: Antimicrobial Peptides of Human Neutrophils

    Principal Investigator: Robert Lehrer, MD

    Agency: NIH/NIAID R37 AI22839-13

    Funding Period: 12/1/94-11/30/02

    Percent Effort: 15%

    Amount of Funding: 223,161

    Title of Project: Topical Protegrins to Prevent STDS and HIV Infection

    Principal Investigator: Robert Lehrer, MD

    Agency: NIH/NIAID P01 AI37945-03

    Funding Period: 3/1/95-2/28/99

    Percent Effort: 10%

    Amount of Funding: 419,795

    Title of Project: Antimicrobial Peptides of Leukocytes

    Principal Investigator: Robert Lehrer, MD

    Agency: NIH/Fogarty R03 TW00355-04

    Funding Period: 2/1/97-1/31/00

    Percent Effort:15%

    Amount of Funding: 20,000

    Title of Project: Salt-tolerant Antimicrobial Peptides

    Principal Investigator: Robert Lehrer, MD

    Agency: Cystic Fibrosis Foundation

    Funding Period: 7/1/97/6/30/00

    Percent Effort: 10%

    Amount of Funding: 99,491

    GeneBank:

    From 1993-2000, found and sequenced about sixty cDNA or gene sequences of antimicrobial peptides from human and various species of animals. All of them were sent to the GeneBank database.

PUBLICATIONS

Books and Chapters

    1.Diagnostic Exfoliative Cytology. Chief editors:Chengquan Zhao, Fang Fan, Rulong Shen, Min Yang. Beijing Science and Technology Press, China. First edition May 2016

    2.Precancerous Lesions of the Gynecologic Tract. Chief editor Oluwole Fadare. Chapter 11 Cytology of cervical precancerous lesions. Zaibo Li, Chengquan Zhao. Spinger, 2015.

    3.Pathological Diagnosis and Differential Diagnosis of Breast Lesions. Chief Editors: Xiangsheng Zhang, Hong Bu, Chengquan Zhao. People’s Medical Publishing House, China. May 2014.

    4.Diagnostic Cytopathology-Fine Needle Aspiration. Chief Editors: Chengquan Zhao, Liron Pantanowitz, Min Yang.Beijing Science and Technology Press, China, 2014.

    5.Schnitt, Laura Collins. Biopsy Interpretation of the Breast. Translation.Chief Revisers,  Chengquan Zhao, Huayie Ding, Xiaojun Zhou. Beijing Science and Technology Press, China.Second edition, 2014.

    6.Clear Cell Tumours Chapter. 2014 WHO Classification of Tumours of the Female Genital Organs. Chief editor: Kurman R, Carcangiu ML, Herrington CS, Young RH.4^th Edit. WHO Press, 2014

    7.Kurman R, Ellenson LH, Ronnett B. Blaustein’s Pathology of the Female Genital Tract. Six Edit. Chinese translation.Chief Revisers: Zhao C, Liu Ai, Yang W, Cao D. Beijing Science and Technology Press, China, 2014.

    8.Human papillomavirus (HPV) infection and cervical lesions. Zhao C. Yang H, Means M, Khalbuss WE. Gynecological and Breast cytopathology board review and self-assessment. Chief Edit Khalbuss WE, Means M. Springer New York, 2013

    9.Gynecological Cytopathology: Brief text book. Chief Editors: Min Yang, Yaohua Cao, Chengquan Zhao, Beijing Science and Technology Press, China.2014.

    10.Gynecological Pathology, Chapter 28:Sex Cord-Stroma Tumor of Ovary. Liu A, Zhao C, Wang J, Zheng W. People’s Medical Publishing House, China, 2013

    11.Fredenck C. Koerner. Diagnostic Problems in Breast Pathology. Translation. Chief Revisers: Ding H, Zou X, Zhao C. People’s Medical Publishing House, China, First Edition, July 2011

    12.Stuart Schnitt, Laura Collins. Biopsy Interpretation of the Breast. Translation.Chief Revisers,  Ding H, Zhao C. Beijing Science and Technology Press, China.First edition, September 2010.

    13.Gynecological Cytology: Diagnosis and Clinical management (Chinese)

    Chief Editor, Zhao C, Yang M. Beijing Science and Technology Press, China. First edition August 2011.

    Chapter 1. Austin RM, Yang M, Zhao C. History and future of gynecologic cytology screening for cervical carcinoma. Page 1-8

    Chapter2.Yang M, Wang J, Zhao C. Cervvical cytology TBS reporting system. Page 9-13

    Chapter3.Zhao C, Zhao S, Yu J. HPV infection and cervical lesions. Page 14-41

    Chapter4.Zhao C, Zhao S. The collection and adequacy of the specimen. Page 42-59

    Chapter5. Yang M, Zhao C.Normal cervical cytology. Page 60-87

    Chapter6.Zhao C, Yang M. Microorganisms ad infections. Page 88-122

    Chapter7.Yang M, Zhao C.Benign cervical lesions, artifact and contamination. Page 123-145.

    Chapter8.Zhao C. Yang M, Li Q. Squamous cell abnormality.Page 146-208

    Chapter9.Zhao C. Bansal M, Yang M, Li Q. Page 206-263

    Chapter 10. Yu J. Zhao C. Unusual genital tract tumors and extrauterine tumors. Page 264-272

    Chapter 11.Zhang S, Zhao C. Cervical cytology of pregnancy. 273-284

    Chapter 12. Zhao C, Bansal M, Huang W.Anal cytology

    Chapter 13. Zhao E, Zhang A. Zhao C. Colposcopic examination, findings, related histology and cytology. 302-320

    Chapter 14. ASCCP guideline for the management of women with abnormal cervical screening test. Translator: Yang W,Reviser: Yang H, Zhao C. page 321-340

    Chapter 16. Chen X, Zhao C. New technologies in cervical cytology. Page 348-357

    Chapter 17. Chen X, Zhao C.Cytopathology quality control and quality assurance in the USA. Page 358-367

    Chapter 18.Austin M, Zhao C. Novel approaches for screening in the post-vaccine era. Page 368-374

    Chapter 19. Austin RM, Zhao C.Lesson learned from the USA Pap test litigation: Perspective from over 200 litigation cervical cancer cases. Page 375-393

    Chapter 20. Chen X, Zhao C.Introduction of gynecological cytology proficiency test. Page 394-399

    Chapter 21.Yang M, Zhao C. Common abbreviation and brief introduction in gynecological cytology and histology. Page 400-409

Refereed Articles:

    1.Zhao C, Crothers BA, Ghofrani, M, Li Z, Souers, RJ,Mojtaba Hussain, M,Fan F, Tolgay Ocal I, Goodrich K, Shen R, Davey DD. CAP Cytopathology Committee. Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists’ National Survey. Arch Pathol Lab Med, Accepted April 2016.

    2.Pradhan D, Li Z, Ocque R, Patadji S, Zhao C (corresponding). Clinical Significance of Atypical Glandular Cells in Pap Tests: Analysis of Over 3000 Cases in a Large Academic Women Center. Cancer Cytopath. Accepted March 2016.

    3.Zhao C, Crothers BA, Ghofrani, M, Li Z,Souers, RJ,Mojtaba Hussain, M,Fan F, Tolgay Ocal I, Davey DD. CAP Cytopathology Committee. HSIL Misinterpretation Papanicolaou Test Rates in the College of American Pathologists Gynecologic PAP Education and PAP Proficiency Test Program. Arch Pathol Lab Med, Accepted January 2016.

    4.Zhao C, Crothers BA, Ghofrani, M, Li Z,Souers, RJ,Mojtaba Hussain, M, Fang Fan F, Tolgay Ocal I, Goodrich KM, Shen R, Davey DD. CAP Cytopathology Committee. Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey. Arch Pathol Lab Med, Accepted Feb 2016.

    5.Tao X, Austin R, Zhang H, Zhang L, Xiao J, Wang L, Zhou X, Zhao C (corresponding). Pap Test Reporting Rates for Conventional Smear and Liquid-Based Cervical Cytology from the Largest Academic Women’s Hospital in China: Analysis of 1,248,785 Papanicolaou Test Reports. Acta Cytologica. 2016 Jan 21 Epub ahead of print.

    6.Zhengyu Zeng, Huaitao Yang, Zaibo Li, Xuekui He,Christopher C. Griffith,Xiamen Chen,Xiaolei Guo,Baowen Zheng, Shangwei Wu,Chengquan Zhao (corresponding). Prevalence and genotype distribution of HPV Infection in China: analysis of 51,345 HPV genotyping results from China’s largest CAP certified laboratory. J Cancer. Accepted 2016 Feb.

    7.Zeng Z, Austin RM, He X, Chen X, Guo X, Zheng B, Wu S, Yang H, Zhao C (corresponding). Prevalence of high risk human papilloma virus infection in China: Analysis of 671,163 human papillomavirus test results from China’s largest CAP-certified laboratory. Am J Clin Pathol. Accepted in October, 2015.

    8.Zheng B, Li Z, Liang X, Austin RM, Chen C, Yan S,Zhao C (corresponding). Squamous Cell Carcinoma Cytology Reporting Rates and Histopathological Follow-up Results:the Experience of China’s Largest College of American Pathologists (CAP) Certified Clinical Laboratory. Acta Cytologica. 2015;59(5):399-404.

    9.Zhao C (corresponding), Wu T, Ding X, Parwani A, Chen H, McHugh J, Piccoli A, Xie Q, Lauro GR, Feng X, Seethala RR, Wu S. Yousem S, Liang Y, Pantanowitz L. International Telepathology Consultation: Three Years of Experience between the University of Pittsburgh Medical Center (UPMC) and KingMed Diagnostics in China.J Pathol Inform 2015;6:63 (27 November 2015).

    10.Tao X, Gu W, Zhou X, Zhao C. The diagnosis and the effort of molecular markers of ovarian tumors. Chin J Pathol. 2015:44(9):686-688.

    11.Li Z, and Zhao C. Clinicopathological and immunohistochemical characterization of dedifferentiated endometrial carcinoma. Appl Immunohistochem Mol Morphol. 2015 Sep 14. [Epub ahead of print]

    12.Li Z, Ranade A, Zhao C. Pathologic Findings of Follow-Up Surgical Excision for Radial Scar on Breast Core Needle Biopsy.Human Pathol 2016:48:76-80

    13.Crothers BA, Darragh TM, Tambouret RH, Nayar R, Barkan GA, Zhao C, Booth CN, Padmanabhan V, Tabatabai ZL, Souers RJ, Thomas N, Wilbur DC, Moriarty AT. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire. Arch Pathol Lab Med. 2016;140(1):13-21

    14.Stoler MH, Austin RM, Zhao C.Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years. J Clin Microbiol. 2015;53(9):2798-804.

    15.Serdy K, Yildiz-Aktas I, Li Z, Zhao C (corresponding).The value of Papanicolaou tests in the diagnosis of endometrial carcinoma: a large cohort from an academic medical center. Am J Clin Pathol. 2016;145(3):350-354

    16.Wang H, Li H, Xing X, Zhao C, Luo B. Genotypic analysis and latent membrane protein 1 expression of Epstein-Barr virus in extranodal NK/T-cell lymphoma from Northern Chinese patients.Arch Virol. 2015 Aug;160(8):2071-4.

    17.Liang H, Griffith CC, Ma L, Ling B, Feng D, Li Z, Zhao C (corresponding). The sensitivity of Pap cytology and HPV testing to detect cervical cancer: prior testing results in 178 patients with invasive cervical cancer at a large general hospital in China. JASC 2016;5:64-70

    18.Zheng B, Griffith CC, Yan S, Chen C, Ding X, Yang H, Zhao C (corresponding). Prior high risk HPV testing and Pap test results of 427 invasive cervical cancers in China’s largest CAP certified laboratory. Cancer Cytopathol. 2015;123(7):428-34.

    19.Tao X, Griffith CC, Zhou X, Wang Z, Yan Y, Li Z, Zhao C (corresponding). History of high risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women’s hospital in China. Cancer Cytopathol. 2015;123(7):421-7.

    20.Ocque R, Zhao C. Negative Pap, positive hrHPV: what we know so far. CAP Today 2015 May:48-49

    21.Woodard A, Austin MR, Li Z, Beere J, Zhao C (corresponding). Prevalence of HPV16/18 genotypes and histopathologic follow-up outcomes in women with negative cytology and positive high risk HPV test results. JASC 2015;4:261-266

    22.Liu S, Wang X, Shi Y, Han L, Zhao Z, Zhao C, Luo B. Toll-like receptor gene polymorphisms and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma in Northern China. Saudi J Gastroenterol. 2015;21(2):95-103

    23.Zhao C (corresponding), Moriarty AT, Ghofrani M, Husain M, Tambouret RH, Laucirica R, Laser A, Fisher A, Ocal IT, Souers RJ, Russell DK, Fan F, Crothers BA. Human Papillomavirus testing and reporting rates in 2012: results of a College of American Pathologist’s (CAP) national survey. Arch Path Lab Med. 2015;139(6):757-61

    24.Barron S, Austin RM, Li Z, Zhao C (corresponding): Follow-up outcomes in a large cohort of patients with HPV-negative LSIL cervical screening test results. Am J Clin Pathol 2015;143(4):485-491

    25.Zheng B, Austin RM, Liang X, Li Z, Chen C, Yan S, Zhao C (corresponding). Positive predictive value (PPV) of a high grade squamous intraepithelial lesion (HSIL) cervical cytology result in China’s largest College of American Pathologists (CAP) certified laboratory. JASC 2015(4):84-89

    26.Yang H, Xue D, Tao X, Li Z, Zhao C (corresponding). Human papilloma virus negative cervical cancer. Zhonghua Bing Li Xue Za Zhi. 2015;44(1):73-76.

    27.Tao X, Zhou X, Zhao C. The advance of ovarian clear cell carcinoma in immunohistochemistry and molecular pathogenesis. Zhonghua Bing Li Xue Za Zhi. Accepted April 2015.

    28.Fadare O, Zhao C, Khabele D, Parkash V, Quick CM, Gwin K, Desouki MM. Comparative analysis of Mapsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumurs. Pathology 2015;47(2):105-111.

    29.Pantanowitz L, McHugh J, Cable W, Zhao C, Parwani AV. Imaging file management to support international telepathology. J Pathol Inform. 2015;6:17

    30.Austin RM, Zhao C.Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening? Cytojournal. 2014 May 22;11:14

    31.Zhao C (corresponding), Zaibo Li, Nayar R, Levi AW, Winkler B, Moriarty AT et al. Prior high-risk HPV testing and Pap test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multi-center study.Arch Pathol Lab Med. 2015;139(2):184-188.

    32.Stoler MH, Austin RM, Zhao C. Cervical cancer screening should be done by primary HPV testing with genotyping and reflex cytology for women over the age of 25 years. J Clinical Microbiology. 2015 May 6 [Epub ahead of print].

    33.Zhao C, Austin MR. The author’s reply. Am J Clin Pathol. 2014;142(2):279

    34.Zheng B, Marshall Austin RM, Liang X, Li Z, Chen C, Yan S, Zhao C (corresponding). Bethesda System Reporting Rates for Conventional Pap Smears and Liquid-based Cytology in a Chinese Large College of American Pathologists Certified Independent Medical Laboratory: Analysis of 1,394,389 Pap Test Reports. Arch Pathol Lab Med. 2015;139(3):373-377.

    35.HPV primary screening. Austin RM, Zhao C. CAP Today. 2014:11:

    36.Marshall RM, Zhao C. Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening? Cytojournal. 2014, 11:14

    37.Barron S, Li Z, Austin RM, Zhao C (corresponding). Low grade squamous intraepithelial lesion/cannot exclude high grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN2+ detection rates. Am J Clin Pathol. 2014;141(2):239-246.

    38.Zhao C (corresponding), Hong W, Li Z, Weng B, Amin M, Austin RM. Human papillomavirus testing and cytologic/histopathologic “test of cure” follow-up results after excisional treatment for high grade cervical intraepithelial neoplasia. J Am Soc Cytopath. 2014; 3(1):15-20

    39.Zhao C (corresponding). Yang H, Li Z. Evidence emerging for HPV-negative cervical cancer. CAP Today 2014;28(1):41-45

    40.Zhao C 2014 PAPW: Online Education Activity, College of American Pathologists enduring internet CME Activity (February 17, 2014 to February 16, 2015)

    41.Desouki MM, Lioyd J, Xu H, Cao D, Barner R, Zhao C (corresponding). CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Hum Pathol. 2013;44(11):2536-41

    42.Crothers BA, Booth CN, Darragh TM, Zhao C, Souers RJ, Thomas N, Moriarty AT. False-positive papanicolaou (PAP) test rates in the College of American Pathologists PAP Education and Pap proficiency test programs. Arch Pathol Lab Med. 2014;138(5):613-619.

    43.Li Z, Fadare O, Hameed O, Zhao C, Desouki MM. Incidence atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer. Hum Pathol, 2014;45:104-109.

    44.Zhao C (corresponding), Li Z. Automated cell block system for atypical glandular cells of cervical cytology: Is it feasible? Cancer Cytopath 2014;122(1):5-7.

    45.Kuhn E, Ayhan A, Bahadirli-Talbott A, Zhao C, Shih I-M. Molecular characterization of undifferentiated carcinoma associated with endometrioid carcinoma. Am J Surg Path. 2014;38(5):660-665

    46.Darragh TM, Winkler B, Souers RJ, Laucirica R, Zhao C, Moriarty AT; College of American Pathologists Cytopathology Committee. Room for improvement: initial experience with anal cytology: observations from the College of American Pathologists interlaboratory comparison program in nongynecologic cytology. Arch Pathol Lab Med. 2013;137(11): 1550-1554.

    47.Fasanella KE, Bista RK, Staton K, Rizvi S, Uttam S, Zhao C, Sepelveda A, Brand RE, McGrath K, Liu Y. Nuclear Nano-architecture Markers of Gastric Cardia and Upper Squamous Esophagus Detect Esophageal Cancer “Field Effect”. J Cancer. 2013 Sep 10;4(8):626-34

    48.Zhao C (corresponding) Li Z, Austin RM. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia. Am J Clin Pathol. 2013;140(1):47-54.

    49.Auger M, Khalbuss WE, Nayar R, Zhao C, Wasserman P, Souers R, Thomas N, Moriarty Ann. Accuracy and false-positive rate of cytologic diagnosis of follicular cervicitis: observation from the College of American Pathologists Pap educational program. Arch Pathol Lab Med. 2013;137(7):907-911

    50.Li Z, Barron S, Hong W, Karunamurthy A, Zhao C (corresponding). Surveillance for Recurrent Cancers and Vaginal Epithelial Lesions in Patients with Invasive Cervical Cancer after Hysterectomy: Are Vaginal Cytology and HrHPV testing Useful. Am J Clin Pathol. 2013;140:708-714.

    51.Cohen D, Austin RM, Gilbert C, Freij R, Zhao C (corresponding). Follow-up outcomes in a large cohort of patients with human papillomavirus-negative ASC-H cervical screening test results. Am J Clin Pathol. 2012;138(4):517-523.

    52.Moriarty AT, Bentz JS, Winkler B, Fischer AH, Laucirica R, Souers R, Thomas N, Zhao C. Proficiency Testing of High Risk Human Papillomavirus DNA Tests: The first 3 years of experience of the College of Pathologists CHPV surveys. Arch Pathol Lab Med. 2013;137(5):606-609.

    53.Zhao C, Yang M. The introduction of the US new screening guideline for cervical carcinoma. Chin J Obstet Gynecol 2013;48(5)

    54.Gao FF, Bhargava R, Yang H, Li Z, Zhao C (corresponding). A clinicopathological study of serous tubal intraepithelial carcinoma and co-existing invasive carcinoma: Is the presence of STIC a reliable feature to determine organ of origin? Hum Pathol. 2013;44(8):1534-1543.

    55.Desouki MM, Li Z, Hameed O, Fadare O, Zhao C (corresponding). Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women’s health center. Hum Pathol. 2013;44(9):1877-1881.

    56.Zhao C (corresponding), Weng B, Li Z, Yang H, Austin RM. Follow-up outcomes of a large cohort of low-risk women with negative imaged liquid-based cytology and negative HPV test results. Am J Clin Pathol. 2013;139(1):32-38.

    57.Zhao C. 2013 PAPW: Online Education Activity, College of American Pathologists enduring internet CME Activity (February 17, 2013 to February 16, 2013)

    58.Li Z, Zhao C. (corresponding).Long-term follow-up results from women with cervical adenocarcinoma-in situ treated by conization: an experience from a large academic women’s hospital. JLGTD. 2013;17:452-458

    59.Li Z, Jie, Zheng H, Zhao C. The clinical significance and treatment for women with endometrial cells in Pap tests. Chin J Pathol. 2013;42:

    60.Zhao C (corresponding), Yang H. Human papillomavirus DNA detection in women with normal and abnormal cervical Pap cytology. Diagnostic Histopathology. 2012;18(8):341-347.

    61.Zhao C. Li Z. endometrial cells in Pap tests-when are they significant? CAP Today 2013 January.

    62.Zhao C, Yang H. Approved assays for detecting HPV DNA-design, indications, and validation. CAP Today 2012:26(1):40-44

    63.Zhao C (corresponding), Yang H, Xie D, Yang M. HPV detection and histological findings in women with different Pap test results. Chin J Pathol. 2012;41(11):774-778

    64.Nie Y, Sun Y, Wang Y, Liu C, Zhao C, Luo B. Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patients. Arch Virol. 2013;158(5):1031-7

    65.Zhao C (corresponding), Yang H, Tian Z, Huang B. FDA approved HPV DNA detection methods, design, indication, and validation. Chin J Pathol; 2012;41(12):855-857.

    66.Alexandrov SA, Uttam S, Bista RK, Zhao C, Liu Y. Real time quantitative visualization of 3D structural information. Opt Express. 2012;20(8):9203:14.

    67.Zhao C (corresponding), Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM. Cytology and HPV screening test results associated with 2827 histopathologic cervical intraepithelial neoplasia 2/3 diagnoses. Arch Pathol Lab Med. 2012 Oct. Epub ahead of print.

    68.Zhao C (corresponding), Desouki MM, Florea A, Mohammed K, Li X, Dabbs D. Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification. Am J Clin Pathol. 2012;138:72-78

    69.Liu X , Tang X, Wang Y, Wang X, Zhao C, Luo B. Methylation and expression of retinoblastoma1 and transforming growth factor-β1 genes in Epstein-Barr virus-associated and –negative gastric carcinomas. Gastroenterology Research and Practice. 2012;2012:906017. Epub 2012 Sep 12.

    70.Heravi-Mussavi A, Anglesio MS, Cheng SWG, Senz J….Young RH, Zhao C, ….Morin GB, Huntsman DG. Recurrent somatic DICER1 mutations in non-epithelial ovarian cancers. New Engl J Med 2012;366:234-242

    71.Austin RM, Zhao C. Unrecognized risks associated with new cervical screening guidelines for younger women. Arch Pathol Lab Med. 2011;135(9):1080

    72.Austin RM, Zhao C. Type 1 and Type 2 cervical carcinomas: Some cervical carcinomas are more difficult to prevent with screening. Cytopathology 2012;23(1):6-12

    73.Wu C, Wang Y, Chao Y, Jia Y, Zhao C, Luo B. Characterization of Epstein-Barr virus type I nuclear antigen 3C sequence patterns of nasopharyngeal and gastric carcinomas in Northern China. Arch Virol 2012;157:845-853.

    74.Zhao C (corresponding), Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM. Cytology and HPV screening test results associated with 2827 histopathologic cervical intraepithelial neoplasia 2/3 diagnoses. Arch Pathol Lab Med. Accepted in June 2012

    75.Zhang XS, Dong HY, Zhang LL, Desouki MM, Zhao C (corresponding). Xanthogranulomatous inflammation in the female genital tract. J Cancer 2012;3:100-106

    76.Zhao C (corresponding), Domfeh A, Austin RM. Histopathologic outcomes and clinical correlations for high risk patients screened with anal cytology.Acta Cytol.2012;56(1):62-7. Epub 2012 Jan 4.

    77.Mona Bansal, Li Z, Zhao C (corresponding). Correlation of histopathologic/cytologic follow-up findings with vaginal ASC-US and ASC-H Pap test and HPV test results. Am J Clin Pathol. 2012;137;437-443

    78.Li X, Weaver O, Desouki MM, Dabbs D, Shyu S, Carter G, Zhao C (corresponding). Microcalcification Is An Important Factor in the Management of Breast Introductal Papillomas Diagnosed on Core Biopsy. Am J Clin Pathol. 2012;138(6):789-795

    79.Li Z, Yang H, Gilbert CM, Zhao C (corresponding). Histologic follow-up in patients with Pap test findings of endometrial cells: results from a large academic womens hospital laboratory. Am J Clin Pathol.2012;138:79-84

    80.Li Z, Austin RM, Guo M, Zhao C (corresponding). Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma. Arch Pathol Lab Med.2012;136(12):1533-1540.

    81.Mentrikoski MJ, Zhao C, Zhang J, Wang HL, McMahon LA, Yang Q, Li F, Xu H. Metastatic endometrial stromal sarcoma of the lung: importance of immunohistochemical staining, clinical history and imaging studies. Biotechnic & Histochem. 2012;87:35-39.

    82.Austin RM, Zhao C. How should “negative” HPV LDT results be verified? Am J Clin Pathol. Accepted April 2012.

    83.Zhao C, Yang H. FDA Approved assays for detecting HPV DNA: design, indication, and validation. CAP today. 2012;26(1):40-44

    84.Bansal M, Austin RM, Zhao C (corresponding). Correlation of Histopathologic Follow-up Findings with Vaginal Human Papillomavirus and LSIL Pap Test Results. Arch Pathol Lab Med. 2011;135:1545-1549

    85.Rao J, Levin M, Zhao C. Premature conclusion on HPV-only testing. Lancet Oncol 2011;12(11):992-993

    86.Cheng JZ, Zhang JP, Yin XG, Li GX, Xu LH, Yang YL, Zhao C, Ren XC, Xue DB. Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor2 Expression in Invasive Apocrine Carcinomas of the Breast. Journal of Bengbu Medical College 2011;36(8)

    87.Gao F, Austin RM, Zhao C (corresponding). Histopathologic follow-up and human papillomavirus DNA test results in 290 Patients with high grade squamous intraepithelial lesion papanicolaou test results. Cancer Cytopathol. 2011;119(6):377-386

    88.Zhao C (corresponding), Chen X, Agnieszka OA, Kanbour A, Austin RM. Follow-up outcomes for a large cohort of U.S. women with negative imaged liquid based cytology findings and positive high risk human papillomavirus test results. Gynecol Oncol. 2011;122:291-296

    89.Luo B, Tang X, Jia Y, Wang Y, Chao Y, Zhao C. Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in North China. Microbes Infect. 2011;13 (8-9):776-782

    90.Austin RM, Zhao C. Observations for Pap litigation consultations. Pathology Case Reviews 2011;16:73-82

    91.Zhao C (corresponding) Wu LSF, Barner R. Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer 2011;2:94-106.

    92.Bansal M, Zhao C (corresponding). Prevalence of High Risk Human Papillomavirus in Women with Abnormal and Normal Vaginal ThinPrep Papanicolaou Cytology. J Low Genit Tract Dis. 2011;15(2):105-109

    93.Bohn OL, Zhao C, Jones MW. Unusual Ovarian Stromal Tumor with Radiation Changes Mimicking Carcinoma. J Cancer 2011;2:228-231

    94.Chao Y, Jing Y, Jia Y, Wang Y, Zhao C, Luo B. Conservation and mutation of viral interleukin-10 gene in gastric carcinomas and nasopharyngeal carcinomas. J Med Virol. 2011;83:644-650

    95.Zhao C (corresponding),Zhao S, Heider A, Austin RM. Significance of high-risk papillomavirus DNA detection in women 50 years and older with squamous cell Pap test abnormalities. Arch Pathol Lab Med. 2010;134(8):1130-1135.

    96.Zhao C (corresponding), Kalposi-Novak P, and Austin RM. Follow-up Findings in Adolescents with HSIL Pap Test Results. Arch Pathol Lab Med. 2011;135:361-364.

    97.Heider, Austin RM, Zhao C (corresponding). Data From a Large University Womens Hospital Practice Support ASCCP Guidelines Citing HPV Triage As An Option with LSIL Cytology for Older Women. Acta Cytol . 2011;55:48-53

    98.Fischer AH, Zhao C, Li QK, Gustafson K, Eltoum IE, Tambouret R, Benstein B, Savaloja L, Kulesza P. (American Society of Cytopathology Cell Biology Liaison Working Group). The Cytologic Criteria of Malignancy. J Cell Biochem. 2010;110(4):795-811.

    99.Zhao C, Florea A, Austin RM. The utility of high risk HPV testing in women with atypical glandular cells. Arch Pathol Lab Med. 2010;134(1):103-108

    100.Bandyopadhyay S, Austin RM, Dabbs D, Zhao C (corresponding).Adjunctive HPV DNA Testing Is a Useful Option in Some Clinical Settings for Disease Risk Assessment and Triage of Women with ASC-H Pap Results. Experiment Lab Med. 2010;28(1):3-5.

    101.Bansal M, Austin RM, Zhao C (corresponding). High Risk HPV DNA detection in less than 2% of over 25,000 cytology negative imaged liquid based Pap test samples from women 30 and older. Gynecol Oncol.2009 115(2):257-61

    102.Zhao S, Sun G ,MA De, Chen R, Dai H, Zhao C. Expression and Methylation Status of the Syk Gene in Cervical Carcinoma. Archives of Gynecology and Obstetrics.Arch Gynecol Obstet. 2011;238(5):1113-1119.

    103.Cui Y, Wang Y, Liu X , Chao Y, Xing X-M , Zhao C, Liu C-Y , Luo B.Genotypical analysis of Epstein-Barr virus isolates associated with naso